Literature DB >> 12531198

Development of intramolecularly quenched fluorescent peptides as substrates of angiotensin-converting enzyme 2.

Zhong-Hua Yan1, Kai-Jun Ren, Yafan Wang, Sharon Chen, Tommy A Brock, Ajay A Rege.   

Abstract

Angiotensin-converting enzyme 2 (ACE2 or ACEH) is a novel angiotensin-converting enzyme-related carboxypeptidase that cleaves a single amino acid from angiotensin I, des-Arg bradykinin, and many other bioactive peptides. Using des-Arg bradykinin as a template, we designed a series of intramolecularly quenched fluorogenic peptide substrates for ACE2. The general structure of the substrates was F-X-Q, in which F was the fluorescent group, Abz, Q was the quenching group (either Phe(NO(2)) or Tyr(NO(2))), and X was the intervening peptide. These substrates were selectively cleaved by recombinant human ACE2, as shown by MS and HPLC. Quenching efficiency increased as the peptide sequence was shortened from 8 to 3 aa, and also when Tyr(NO(2)) was used as a quenching group instead of Phe(NO(2)). Two of the optimized substrates, TBC5180 and TBC5182, produced a signal:noise ratio of better than 20 when hydrolyzed by ACE2. Kinetic measurements with ACE2 were as follows: TBC5180, K(m)=58 microM and k(cat)/K(m)=1.3x10(5)M(-1)s(-1); TBC5182, K(m)=23 microM and k(cat)/K(m)=3.5 x 10(4)M(-1)s(-1). Thus, based on hydrolysis rate, TBC5180 was a better substrate than TBC5182. However, TBC5180 was also hydrolyzed by ACE, whereas TBC5182 was not cleaved, suggesting that TBC5182 was a selective for ACE2. We conclude that these two peptides can be used as fluorescent substrates for high-throughput screening for selective inhibitors of ACE2 enzyme.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531198     DOI: 10.1016/s0003-2697(02)00461-x

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  6 in total

Review 1.  Integrative Physiological Aspects of Brain RAS in Hypertension.

Authors:  Sharon D B de Morais; Julia Shanks; Irving H Zucker
Journal:  Curr Hypertens Rep       Date:  2018-02-26       Impact factor: 5.369

2.  Activatable Optical Probes for the Detection of Enzymes.

Authors:  Christopher R Drake; David C Miller; Ella F Jones
Journal:  Curr Org Synth       Date:  2011-08       Impact factor: 1.975

3.  Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients.

Authors:  Peio Errarte; Maider Beitia; Itxaro Perez; Lorea Manterola; Charles H Lawrie; Jon Danel Solano-Iturri; Julio Calvete-Candenas; Miguel Unda; José I López; Gorka Larrinaga
Journal:  PLoS One       Date:  2017-08-15       Impact factor: 3.240

4.  Angiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats.

Authors:  Hui Ma; Jing Kong; Yu-Lin Wang; Jun-Long Li; Nai-Hao Hei; Xin-Ran Cao; Jing-Jing Yang; Wen-Jiang Yan; Wen-Jing Liang; Hong-Yan Dai; Bo Dong
Journal:  Oncotarget       Date:  2017-04-11

5.  Purification and characterization of angiotensin converting enzyme 2 (ACE2) from murine model of mesangial cell in culture.

Authors:  Danielle S Aragão; Tatiana S Cunha; Danielle Yuri Arita; Maria Claudina C Andrade; Adriana B Fernandes; Ingrid K M Watanabe; Renato A Mortara; Dulce Elena Casarini
Journal:  Int J Biol Macromol       Date:  2011-04-04       Impact factor: 6.953

6.  Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice.

Authors:  Khalid M Elased; Tatiana Sousa Cunha; Fernanda Klein Marcondes; Mariana Morris
Journal:  Exp Physiol       Date:  2008-02-08       Impact factor: 2.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.